Regenxbio Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 28.0% | 19.5% | 20.0% | 20.1% | 51.1% | 675.9% | 1.8% | 9.7% | 9.7% | 7.0% | 3.3% | 24.5% | 17.0% | 32.2% | 19.3% | 28.3% | 17.6% | 47.8% | 25.7% | 44.6% | 45.8% | 5.8% | 70.7% | 39.7% | 49.4% | 40.8% | 21.5% | 47.4% | 42.8% | 70.1% | 54.2% | 65.6% | 51.2% | 29.8% | 3.9% | 42.7% | 207.9% | 19.5% | 173.2% | 1.0% | 45.8% | |
| 72.0% | 80.5% | 80.0% | 79.9% | 48.9% | -575.9% | 98.2% | 90.3% | 90.3% | 93.0% | 96.7% | 75.5% | 83.0% | 67.8% | 80.7% | 71.7% | 82.4% | 52.2% | 74.3% | 55.4% | 54.2% | 94.2% | 29.3% | 60.3% | 50.6% | 59.2% | 78.5% | 52.6% | 57.2% | 29.9% | 45.8% | 34.4% | 48.8% | 70.2% | 96.1% | 57.3% | -107.9% | 80.5% | -73.2% | 99.0% | 54.2% | |
| 10,048.0% | 946.9% | 3,652.5% | 212.1% | 937.0% | 694.6% | 14.8% | 53.7% | 348.8% | 59.7% | 2,851.0% | 374.1% | 242.8% | 287.3% | 209.9% | 230.1% | 44.5% | 220.0% | 210.3% | 208.2% | 155.5% | 12.0% | 250.4% | 186.9% | 238.8% | 199.4% | 305.8% | 299.8% | 201.2% | 231.2% | 324.3% | 201.0% | 224.9% | 237.5% | 59.6% | 260.3% | 188.7% | 196.5% | 896.9% | 51.9% | 131.3% | |
| 4,960.0% | 338.6% | 1,455.4% | 96.8% | 706.9% | 235.7% | 6.3% | 20.8% | 169.8% | 27.3% | 1,307.5% | 170.1% | 84.4% | 122.8% | 84.1% | 93.9% | 16.0% | 81.9% | 94.5% | 83.6% | 68.3% | 5.5% | 100.5% | 63.8% | 78.9% | 67.7% | 118.3% | 118.6% | 79.8% | 85.9% | 117.1% | 84.6% | 80.3% | 94.5% | 22.9% | 93.1% | 68.1% | 73.8% | 333.3% | 20.0% | 49.0% | |
| 15,006.4% | 1,287.4% | 5,117.8% | 309.4% | 1,643.9% | 932.4% | 21.1% | 74.5% | 518.5% | 87.0% | 4,158.5% | 543.4% | 327.2% | 410.4% | 294.3% | 324.2% | 68.3% | 302.4% | 307.5% | 292.5% | 240.5% | 15.6% | 351.2% | 251.9% | 318.6% | 243.5% | 424.2% | 418.5% | 281.8% | 317.6% | 441.2% | 285.7% | 305.4% | 312.4% | 82.5% | 353.6% | 68.3% | 270.4% | 1,230.7% | 71.9% | 148.3% | |
| -14,934.4% | -1,206.9% | -5,037.8% | -229.4% | -1,595.0% | -813.6% | 77.1% | 15.9% | -428.3% | 6.0% | -4,061.8% | -467.9% | -244.2% | -342.7% | -213.7% | -252.5% | 14.1% | -250.2% | -233.2% | -237.0% | -186.4% | 78.7% | -321.9% | -191.5% | -268.0% | -184.3% | -345.7% | -366.0% | -224.7% | -287.7% | -395.4% | -251.3% | -256.6% | -242.1% | 13.6% | -296.3% | -176.3% | -190.0% | -1,304.0% | 27.1% | -94.1% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | 3.6% | 35.5% | 28.9% | 21.8% | 1.6% | 27.6% | 21.0% | 22.5% | 13.8% | 14.4% | 5.6% | 5.6% | 6.1% | 12.6% | 2.0% | 3.4% | 44.4% | 9.6% | 51.5% | 44.3% | 40.5% | 136.2% | 7.2% | 24.0% | |
| -14,523.2% | -1,181.8% | -4,833.6% | -220.6% | -1,549.9% | -784.2% | 78.7% | 36.1% | -386.2% | 14.5% | -3,653.6% | -20.1% | -236.4% | -245.2% | -226.9% | -206.8% | 8.9% | -188.8% | -265.5% | -261.6% | -189.8% | 77.1% | -345.5% | -208.8% | -284.7% | -191.3% | -348.4% | -360.7% | -214.0% | -283.8% | -405.4% | -237.7% | -246.3% | -241.3% | 6.8% | -331.8% | -208.3% | -221.3% | -1,408.6% | 21.0% | -112.6% | |
| -411.2% | -25.6% | -204.2% | -8.9% | -45.1% | -64.9% | -0.1% | 9.6% | -24.3% | 4.0% | -7.9% | -1.6% | -1.1% | -20.3% | 13.3% | -3.0% | 0.0% | 26.8% | 0.0% | 28.9% | 21.8% | 3.4% | -0.2% | 21.0% | 16.7% | -0.1% | 17.1% | 5.6% | -9.5% | -0.7% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| -14,523.2% | -1,156.1% | -4,833.6% | -220.6% | -1,549.9% | -784.2% | 78.7% | 26.5% | -361.9% | 10.6% | -3,645.7% | -18.5% | -235.3% | -224.9% | -226.9% | -203.8% | 8.9% | -215.6% | -265.5% | -261.6% | -189.8% | 73.8% | -345.3% | -208.8% | -284.7% | -191.2% | -348.4% | -360.7% | -214.0% | -283.1% | -405.4% | -237.7% | -246.3% | -241.3% | 6.8% | -331.8% | -208.3% | -221.3% | -1,408.6% | 21.0% | -112.6% | |
| -14,806.4% | -1,165.3% | -4,916.0% | -218.7% | -1,542.1% | -778.2% | 77.7% | 18.1% | -410.6% | 9.2% | -3,879.2% | -445.7% | -231.5% | -326.3% | -215.6% | -194.0% | 11.1% | -175.4% | -219.8% | -222.7% | -158.8% | 79.4% | -306.3% | -179.7% | -248.9% | -164.4% | -312.2% | -332.9% | -193.2% | -258.2% | -366.0% | -217.5% | -226.5% | -177.9% | 20.9% | -262.1% | -151.0% | -168.1% | -1,212.0% | 31.7% | -79.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.